The Community of Madrid and the Ministry of Health have starred on Thursday a shock following the financing of a childhood leukemia medicine, Blinatumomab monoclonal antibodywith which the Regional Government emphasizes that the autonomous communities are paid in front of a minister, Mónica García, who maintains that she is available to those who need it in hospitals.
During the plenary of the Madrid Assembly on Thursday, the regional president, Isabel Díaz Ayuso, has recriminated to more Madrid, the Mónica García party, “Deny the sanitary drug to children with cancer, the main drug” And thus harm public health.
In a message in her personal account of the social network ‘X’, the minister and leader of Más Madrid has responded to this accusation accusing the regional president of “lying.” “This medicine for childhood leukemia It is already being bought in hospitals and managing who needs it. The decision was in 2017 under a PP government, “he said in relation to the Mariano Rajoy Executive.
According to the minister, currently “centralized financing is being negotiated to guarantee the best price”. Likewise, Mónica García has accused Ayuso of lying when he affirms that it is the “main drug” to treat childhood leukemia.
“I hope it was so simple … Childhood cancer is complex and these statements do not help. It is necessary serious work, research and responsible decisions, not bulls to do politics, “the minister has written in this social network.
Foreign drug price
Specifically, it is a drug that heals a type of blood -blooded cancer that is the acute lymphoblastic leukemia In children and also serves some cases in adults. As defended by the Minister of Health of the Community of Madrid, Fatima Matute, the autonomous communities “are already a price of foreign drug”.
The head of Madrid’s Health explained that at the last meeting to set prices The Ministry “denied it for precisely budgetary causes” For the National Health System (SNS). “He did not denied him because he was not indicated and what he is saying now is that yes, that he is being bought in hospitals, of course, at the expense of the autonomous communities and as something special, as a compassionate treatment that serves to save lives.”
In line, he has demanded that this drug “be part of the services portfolio of the National Health System and is financed by the Ministry.” “The minister has the little sensitivity in saying that this drug is already being purchased; obviously, because in the autonomous communities we save lives, which is what matters to us, and we buy that drug as if it were a foreign drug to give it to all patients They need it, “he insisted.
As completed, In the Community of Madrid this drug is financed for 30 patientswhich deals with acute lymphoblastic leukemia type B in children and in some adults and in those selected cases “only that can save their lives.”
“The ministry is not doing anything, it does not have it in the portfolio, it does not finance it and it is the autonomous communities that, at the request of the professionals, we buy the drug but as if it were something foreign, just as it happened with the triple metastatic of Mama that in the end had to finance it.
#Rifirrafe #Ayuso #Mónica #García #financing #key #medicine #child #leukemia
